LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease
Yuri L. Sosero, Eric Yu, Lynne Krohn, Uladzislau Rudakou, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Stanley Fahn, Cheryl Waters, S. Pablo Sardi, International Parkinson Disease Genomics Consortium (IPDGC), Sara Bandres-Ciga, Roy N. Alcalay, Ziv Gan-Or, Konstantin Senkevich
doi: https://doi.org/10.1101/2020.09.23.20197558
Yuri L. Sosero
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
2Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
MDEric Yu
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
2Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
BScLynne Krohn
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
2Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
MScUladzislau Rudakou
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
2Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
MScKheireddin Mufti
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
2Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
MScJennifer A. Ruskey
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and neurosurgery, McGill University, Montréal, QC, H3A 0G4, Canada, Canada
MScFarnaz Asayesh
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and neurosurgery, McGill University, Montréal, QC, H3A 0G4, Canada, Canada
MScSandra B. Laurent
3Department of Neurology and neurosurgery, McGill University, Montréal, QC, H3A 0G4, Canada, Canada
BScDan Spiegelman
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
MScStanley Fahn
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
MDCheryl Waters
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
MDS. Pablo Sardi
5Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, MA, USA
PhDSara Bandres-Ciga
6Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
PhDRoy N. Alcalay
4Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
7Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA
MD, MScZiv Gan-Or
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
2Department of Human Genetics, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and neurosurgery, McGill University, Montréal, QC, H3A 0G4, Canada, Canada
MD, PhDKonstantin Senkevich
1Montreal Neurological Institute, McGill University, Montréal, QC, H3A 1A1, Canada
3Department of Neurology and neurosurgery, McGill University, Montréal, QC, H3A 0G4, Canada, Canada
MD, PhD
Posted September 24, 2020.
LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease
Yuri L. Sosero, Eric Yu, Lynne Krohn, Uladzislau Rudakou, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Stanley Fahn, Cheryl Waters, S. Pablo Sardi, International Parkinson Disease Genomics Consortium (IPDGC), Sara Bandres-Ciga, Roy N. Alcalay, Ziv Gan-Or, Konstantin Senkevich
medRxiv 2020.09.23.20197558; doi: https://doi.org/10.1101/2020.09.23.20197558
LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease
Yuri L. Sosero, Eric Yu, Lynne Krohn, Uladzislau Rudakou, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent, Dan Spiegelman, Stanley Fahn, Cheryl Waters, S. Pablo Sardi, International Parkinson Disease Genomics Consortium (IPDGC), Sara Bandres-Ciga, Roy N. Alcalay, Ziv Gan-Or, Konstantin Senkevich
medRxiv 2020.09.23.20197558; doi: https://doi.org/10.1101/2020.09.23.20197558
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2780)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12430)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4297)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4072)
- Nursing (218)
- Nutrition (603)
- Oncology (2154)
- Ophthalmology (608)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6677)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)